CDP Venture Capital's Biotechnology Portfolio

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.

Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.

GeneSys Bio's portable AI system detects pathogens and AMR in < 30 mins with >98% sensitivity, replacing slow lab tests and saving lives.

Naturbeads is scaling up the technology to manufacture cellulose beads and replace plastic microbeads intentionally added to many products

Developing analytical systems to characterize next-generation cancer immunotherapy

IAMA Therapeutics is a pharmaceutical business that develops novel therapeutics for unmet medical needs in the brain.

Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases

Arsenale is an innovative end-to-end bio-manufacturing platform integrating hardware, data, and AI to produce at scale.

Sustainable, high performance aquaculture feeds

ExoLab Italia is a biotechnological company that provides research, development and production of products.

NanoPhoria develops non-viral, nano-delivery systems for cardiovascular treatments, focusing on inhalable biologics.

Yeastime's value proposition is its innovative retrofitting ultrasound technology, which accelerates fermentation by up to 30%.

Digital biotech startup offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for rare diseases

Valo Therapeutics is an immunotherapy company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.

GI develops super-resolution optical microscopes, empowering researchers to explore the microscopic world with unprecedented detail.

Hypesound is revolutionizing the fermentation industry with its innovative sound wave technology.

Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.

MOGU is a European company, based in Italy, developing a range of mycelium-based technologies.

Morphocell Technologies is a regenerative medicine company.

Neuron Guard is developing a medical device the new standard of care for targeted temperature management of brain damages.

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

SQIM is a biotechnological based agency.

Wood-derived bone implants for patients with bone fractures.

Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.